The FDA expanded treatment options for cancers of the breast, lung, pancreas, and more during the third quarter of 2026. Learn how these new approvals fit into the therapeutic landscape on the #AACRBlog: buff.ly/mY5QpZ3
American Association for Cancer Research (AACR)
@theaacr.bsky.social
The mission of the American Association for Cancer Research (AACR) is to prevent and cure cancer through research, education, communication, collaboration, science policy and advocacy, and funding for cancer research.
The @US_FDA approved the BTK inhibitor pirtobrutinib for adults with previously untreated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) with no known 17p deletion: buff.ly/BVGXVtH
FDA approves pirtobrutinib for previously untreated chronic lymphocyti
On October 2, 2026, the Food and Drug Administration approved pirtobrutinib (Jaypirca, Eli Lilly and Company) for adult patients with previously untreated chronic lymphocytic leukemia (CLL) or small…
buff.ly
The AACR invites professional journalists to submit entries for the 2027 AACR June L. Biedler Prize for Cancer Journalism. The $5,000 prize honors excellence in cancer reporting for the lay public. Learn more: buff.ly/K04idRc
The AACR June L. Biedler Prize for Cancer Journalism
The AACR June L. Biedler Prize for Cancer Journalism is a program of the AACR to raise awareness of the critical role that the media play in educating the public about cancer and cancer research.
buff.ly
Comparing radiation approaches for large brain metastases, a new SERD regimen reduces progression risk in advanced breast cancer, and more. Read the Week in Cancer News from Cancer Today. buff.ly/wj35F8q
The Week in Cancer News: Splitting Radiation Doses for Brain Metastases | Cancer Today
Radiation delivered over several sessions reduced recurrence for large brain metastases, and an experimental SERD may delay progression in breast cancer.
buff.ly
Submit an abstract by October 29 for the AACR Special Conference on Redefining Lung Cancer (January 14-17; San Diego), held in association with the AACR Lung Cancer Task Force and chaired by Charles Swanton. Learn more: buff.ly/keg0wCw #AACRlung27
Abstract submission is now open for the AACR Annual Meeting 2027 (April 2-7). Submit your abstract by November 10 and join us in Orlando to share the latest advances in cancer science and medicine. Learn more: buff.ly/WuSSXNE #AACR27
To kick off #BreastCancerAwarenessMonth, actress Amanda Peet discussed her recent lobular breast cancer diagnosis on the @TODAYshow. She also shared her story—including how her diagnosis challenged her assumptions about breast cancer—with @CancerTodayMag: buff.ly/DS2ZrRT @todayshow.com
Amanda Peet Discusses Her Lobular Breast Cancer Diagnosis | Cancer Today
The ‘Your Friends & Neighbors’ actress explains how her diagnosis challenged many of her assumptions about breast cancer.
buff.ly
Submissions for the 2027 AACR June L. Biedler Prize for Cancer Journalism are open. This $5,000 award recognizes professional journalists who have produced informative and compelling stories that have enhanced the public's understanding of cancer. Learn more: buff.ly/K04idRc
The AACR June L. Biedler Prize for Cancer Journalism
The AACR June L. Biedler Prize for Cancer Journalism is a program of the AACR to raise awareness of the critical role that the media play in educating the public about cancer and cancer research.
buff.ly
The AACR Special Conference on Pediatric Cancer kicked off with talks from Charles Mullighan and Nicole Michmerhuizen, who discussed how genomics reveals novel biological insights into pediatric leukemia. Learn more on the #AACRBlog: buff.ly/VRibpBw #AACRpediatric26
Genomics Reveal New Layers of Pediatric Leukemia Biology
At the AACR Special Conference on Pediatric Cancer, Charles Mullighan and Nicole Michmerhuizen spoke about pediatric leukemia research.
buff.ly
Submit an abstract by October 21 for the AACR Special Conference on Cancer Biology-informed Radioligand Therapy (January 7-10; San Diego), chaired by Kayvan Keshari, David Piwnica-Worms, Julie L. Sutcliffe, and David A. Tuveson. buff.ly/gVPJ8ey #aacrRLT27
Chemotherapy at home? Early research suggests some people may be able to get chemotherapy infusions in the comfort of their homes. buff.ly/vhhmTxv
Chemotherapy at Home | Cancer Today
A pilot program shows some people with cancer may safely receive chemotherapy at home.
buff.ly
Actress Amanda Peet spoke with Cancer Today about her cancer diagnosis, learning about lobular breast cancer, and making difficult treatment decisions. Read the full story: buff.ly/DS2ZrRT
Amanda Peet Discusses Her Lobular Breast Cancer Diagnosis | Cancer Today
The ‘Your Friends & Neighbors’ actress explains how her diagnosis challenged many of her assumptions about breast cancer.
buff.ly
Register by October 27 to get the lowest rates for the AACR Conference on Advances in the Pathogenesis and Immune Therapies of Liver Cancer (December 6-8; Austin, Texas), chaired by Richard S. Finn, Josep M. Llovet, and Jessica Zucman-Rossi. buff.ly/QuyRLts #AACRliver26 @zucmanrossi.bsky.social
AACR and Kids Beating Cancer announced a new grant at the AACR Special Conference on Pediatric Cancer that will fund researchers who are studying pediatric leukemia. Read more about this new collaboration and the grant on the #AACRBlog: buff.ly/Kp7EVE4 #AACRpediatric26
AACR and Kids Beating Cancer Launch New Grant to Advance Pediatric Leukemia Research
AACR and Kids Beating Cancer launched a new grant to support research aimed at improving outcomes for children with high-risk leukemia.
buff.ly
Cochairs Andrew J. Aguirre, Florencia McAllister, Kenneth P. Olive, Eileen O’Reilly, Diane M. Simeone, and Colin D. Weekes adjourned the #AACRpan26 conference. We thank the cochairs, speakers, and abstract presenters for their contributions to this outstanding program.
@fertiglab.bsky.social, @hartjackson.bsky.social, @linghua-wang.bsky.social, Deniz G. Olgun, and Sungsik Kim discussed "Spatial Biology and Actionable Tumor Ecosystems: Beyond the Pretty Picture" to close out the AACR Conference on Pancreatic Cancer. #AACRpan26
Conference cochairs Eileen O’Reilly and Colin D. Weekes joined Christoph Benedikt Westphalen and Tanios Bekaii-Saab to discuss "Smarter Clinical Trials and Precision Development" in a plenary at #AACRpan26. @benwestphalen.bsky.social
Submit an abstract by November 2 for the AACR Conference on Targeting RAS: Mechanisms, Novel Therapeutics, and Clinical Impact (January 28-31; San Diego), chaired by Ryan B. Corcoran, Julian Downward, Ignacio Garrido-Laguna, and Sandra Misale. buff.ly/i0N1m1e #AACRras27 @sandramisale.bsky.social
The final day of the AACR Conference on New Frontiers in the Biology of and Therapeutic Development for Pancreatic Cancer will feature sessions on tumor ecosystems and improved clinical trials. #AACRpan26
An FDA committee votes to support a blood-based multi-cancer early detection test, a treatment combination is approved for advanced breast cancer, and more in the Week in Cancer News from Cancer Today magazine. buff.ly/WisAMFQ
The Desmoplastic and Neural Microenvironment of Pancreatic Cancer: Andreas Trumpp, Nina Steele, Min Li, Noor Shakfa, and Joshua H. Choe addressed this topic in a plenary session at the AACR Conference on Pancreatic Cancer. #AACRpan26
Day 3 of the AACR Conference on Pancreatic Cancer begins soon, featuring sessions on RAS inhibition and reimagining immunotherapy. #AACRpan26
At the annual Party with a Purpose, the Friends of the AACR Foundation will be honoring two scientists, Robert Vonderheide and Andrew Rech of @penncancer.bsky.social, for their efforts in advancing cancer immunotherapies. Read more about the honorees on the #AACRBlog: buff.ly/PKQ3AXT
Party With a Purpose Honors the Power of Immunotherapy
At Party with a Purpose 2026, Robert Vonderheide and Andrew Rech will be honored for their efforts in advancing cancer immunotherapies.
buff.ly
From Detection to Interception: Redefining the Earliest Stages of Pancreatic Cancer—#AACRpan26 cochair Diane M. Simeone, Ben Z. Stanger, Nuria Mallats, Raymond Wadlow, and Sahar Nissim addressed this topic in a plenary at the AACR Conference on Pancreatic Cancer.
The first full day of the AACR Conference on Pancreatic Cancer begins soon, featuring sessions on integrating AI in cancer modeling and detecting and intercepting early stage cancer. #AACRpan26
An FDA committee votes to support a blood-based multi-cancer early detection test, a treatment combination is approved for advanced breast cancer, and more in the Week in Cancer News from Cancer Today magazine. buff.ly/WisAMFQ
The AACR Conference on New Frontiers in the Biology of and Therapeutic Development for Pancreatic Cancer opens this evening in San Diego with a keynote lecture by Andrew J. Aguirre. #AACRpan26
Register by December 15 to get the lowest rates for the AACR Special Conference on Redefining Lung Cancer (January 14-17; San Diego), held in association with the AACR Lung Cancer Task Force and chaired by Charles Swanton. Learn more: buff.ly/hGLGu07 #AACRlung27 @charlesswanton.bsky.social
The @US_FDA approved a combination of the targeted therapies belzutifan and lenvatinib for adults with advanced clear cell renal cell carcinoma who were previously treated with a PD-1 or PD-L1 inhibitor: buff.ly/Ea8dkXM
FDA approves belzutifan in combination with lenvatinib
On September 24, 2026, FDA approved belzutifan in combination with lenvatinib for adults with advanced renal cell carcinoma.
buff.ly
Transformative Technologies for Clinical Care: Brian Compton, Jill Rubinstein, Laura A. T. Kagami, Liya Xu, and Allegra G. Hawkins addressed this topic in a plenary to close out the AACR Conference on Bridging Discovery and Clinical Impact in Pediatric Cancer. #AACRpediatric26
